tPA by telephone: Extending the benefits of a comprehensive stroke center

Neurology

Volumn 64, Issue 1, 2005, Pages 154-156

  Frey, J L ^a,b   Jahnke, H K ^a   Goslar, P W ^a   Partovi, S ^a   Flaster, M S ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b Stroke Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; COMMUNITY HOSPITAL; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESIDENTIAL CARE; SOCIAL SUPPORT; STROKE; TELEPHONE;

EID: 11444264186     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000148595.05198.D6     Document Type: Article

References (10)

1. O'Connor RE, McGraw P, Edelsohn L. Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment. Ann Emerg Med 1999;33:9-14.
2. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment With Alteplase to Reverse Stroke (STARS) study. JAMA 2000;283:1145-1150.
3. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility. Neurology 2001;56:1015-1020.
4. Solomon RC, Hoffman JE. TPA for acute ischemic stroke: the standard of care? Am Coll Emerg Phys [online] 2001. Available at: www.acep.org/1,5005,0. html. Accessed June 3, 2003.
5. Adams HP, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke. Stroke 2003;34:1056-1083.
6. Frey JL, Jahnke HK, Bulfinch EW. Differences in stroke between white, Hispanic, and Native American patients: the Barrow Neurological Institute Stroke Database. Stroke 1998;29:29-33.
7. Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC, for the OSF Stroke Team. Treating acute stroke patients with intravenous tPA: the OSF Stroke Network experience. Stroke 2000;31:77-81.
8. Rymer MM, Thurtchley D, Summers D. Expanded modes of tissue plasminogen activator delivery in a comprehensive stroke center increases regional acute stroke interventions. Stroke 2003;34:e58-e60.
9. Lamonte MP, Bahouth MN, Hu P, et al. Telemedicine for acute stroke: triumph and pitfalls. Stroke 2003;34:725-728.
10. Grotta JC, Burgin WS, El-Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol 2001;58:2009-2013.